Highlights Clinuvel Pharmaceuticals Limited Deutsche Boerse AG

Equities

UR9

AU000000CUV3

Real-time Estimate Tradegate Other stock markets 03:00:26 2024-07-05 EDT			5-day change	1st Jan Change
10.68 ^EUR	+14.40%		+13.90%	+6.91%

06-28	Clinuvel Pharmaceuticals Limited Announces Change of Company Secretary	CI
06-24	Clinuvel Pharmaceuticals Secures Orphan Drug Designation in Europe for Metabolic Disorder Drug	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Clinuvel Pharmaceuticals Secures Orphan Drug Designation in Europe for Metabolic Disorder Drug	06-23	MT
CLINUVEL Announces A Novel Clinical Program	06-17	CI
Clinuvel Pharmaceuticals Partners Valentech Pharma to Introduce EPP Drug in Latin America	05-22	MT
Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3%	04-28	MT
Clinuvel Pharmaceuticals Launches Share Buyback Program	03-14	MT
Clinuvel Pharmaceuticals Limited announces an Equity Buyback for 1,500,000 shares, representing 2.99% of its issued share capital.	03-13	CI
Clinuvel Pharmaceuticals Limited authorizes a Buyback Plan.	03-13	CI
Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-21	CI
Ex-dividend day for final dividend	23-09-04	FA
Clinuvel Pharmaceuticals Limited Announces Dividend for the Full Year Ended June 30, 2023, Payable on September 20, 2023	23-08-28	CI
Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-28	CI
Clinuvel Pharmaceuticals Secures Supply Contract for Porphyria Medication with the US Department of Veterans Affairs	23-07-26	MT
Clinuvel Pharmaceuticals Secures Patents for Melanocortins for Treatment of Central Nervous System Disorders	23-07-13	MT
Clinuvel Pharmaceuticals Limited Announces Technical Note - CUV803 Study and AIS	23-03-19	CI
Clinuvel Pharmaceuticals Limited Announces First Stroke Patient Treated with PRENUMBRA Instant	23-03-19	CI
Clinuvel Pharmaceuticals Limited Present DNA Repair Data At American Academy of Dermatology Meeting	23-03-16	CI
Clinuvel Pharmaceuticals Launches Skin Protection Product	23-02-28	MT
Clinuvel Launches Cyacle, Next Generation Solar Care	23-02-28	CI
CLINUVEL Launches First Dermatocosmetic Product	23-02-28	CI
Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Clinuvel Pharmaceuticals Limited Deutsche Boerse AG

Equities

UR9

AU000000CUV3

Highlights

Filters